Search results
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
Morningstar· 6 days agoThe European Commission is expected...
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 6 days agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
Benzinga· 6 days agoOn Friday, the FDA extended the target action date of priority review of supplemental application...
EMA backs approving Sanofi's Dupixent for 'smoker's lungs', FDA extends review
Reuters via AOL· 6 days agoFrench drugmaker Sanofi and its U.S. partner have been counting on expanding the use of the drug as...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoThe US Food and Drug Administration (FDA) has extended by three months the target action date of its priority review of the supplemental Biologics License Application (sBLA) for Dupixent ...
The Parasitic Worms that Transformed Our Immune Sy | Newswise
Newswise· 1 day agoSummer is near, flowers are blooming, and more than one in four Americans have seasonal allergies....